+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drugs For Erectile Dysfunction Global Market Report 2020

  • ID: 4856005
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Bonro Medical
  • Coloplast A/S
  • Eli Lilly and Co.
  • Futura Medical
  • Pfizer
  • MORE
Drugs For Erectile Dysfunction Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global drugs for erectile dysfunction market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the drugs for erectile dysfunction? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs For Erectile Dysfunction Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Drugs: Sildenafil Citrate, Mirodenafil , Vardenafil 2) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By Mode of Administration: Oral, Topical, Injections
  • Companies Mentioned: Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd, Vivus
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Bonro Medical
  • Coloplast A/S
  • Eli Lilly and Co.
  • Futura Medical
  • Pfizer
  • MORE
1. Executive Summary

2. Drugs For Erectile Dysfunction Market Characteristics

3. Drugs For Erectile Dysfunction Market Size And Growth
3.1. Global Drugs For Erectile Dysfunction Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Drugs For Erectile Dysfunction Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Drugs For Erectile Dysfunction Market Segmentation
4.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Sildenafil Citrate Mirodenafil
  • Vardenafil Tadalafil
  • Udenafil Stendra/ Spedra
  • Lodenafil Carbonate
4.2. Global Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies Retail Pharmacies
  • Online Pharmacies
4.3. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral Topical
  • Injections
5. Drugs For Erectile Dysfunction Market Regional And Country Analysis
5.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Drugs For Erectile Dysfunction Market
6.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview
6.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Drugs For Erectile Dysfunction Market
7.1. China Drugs For Erectile Dysfunction Market Overview
7.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Drugs For Erectile Dysfunction Market
8.1. India Drugs For Erectile Dysfunction Market Overview
8.2. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Drugs For Erectile Dysfunction Market
9.1. Japan Drugs For Erectile Dysfunction Market Overview
9.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Drugs For Erectile Dysfunction Market
10.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Drugs For Erectile Dysfunction Market
11.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Drugs For Erectile Dysfunction Market
12.1. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Drugs For Erectile Dysfunction Market
13.1. Western Europe Drugs For Erectile Dysfunction Market Overview
13.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Drugs For Erectile Dysfunction Market
14.1. UK Drugs For Erectile Dysfunction Market Overview
14.2. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Drugs For Erectile Dysfunction Market
15.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Drugs For Erectile Dysfunction Market
16.4. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Drugs For Erectile Dysfunction Market
17.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview
17.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Drugs For Erectile Dysfunction Market
18.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Drugs For Erectile Dysfunction Market
19.1. North America Drugs For Erectile Dysfunction Market Overview
19.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Drugs For Erectile Dysfunction Market
20.1. USA Drugs For Erectile Dysfunction Market Overview
20.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Drugs For Erectile Dysfunction Market
21.1. South America Drugs For Erectile Dysfunction Market Overview
21.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Drugs For Erectile Dysfunction Market
22.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Drugs For Erectile Dysfunction Market
23.1. Middle East Drugs For Erectile Dysfunction Market Overview
23.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Drugs For Erectile Dysfunction Market
24.1. Africa Drugs For Erectile Dysfunction Market Overview
24.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles
25.1. Drugs For Erectile Dysfunction Market Competitive Landscape
25.2. Drugs For Erectile Dysfunction Market Company Profiles
25.2.1. Eli Lilly and Co.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Pfizer
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Bayer AG
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Dong-A Pharmaceutical Co. Ltd
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Vivus
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market

27. Drugs For Erectile Dysfunction Market Trends And Strategies

28. Product Pipeline Analysis

29. Drugs For Erectile Dysfunction Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Bonro Medical
  • Coloplast A/S
  • Eli Lilly and Co.
  • Futura Medical
  • Pfizer
  • MORE
The erectile dysfunction (ED) drugs market consists of sales of erectile dysfunction (ED) drugs and related services. Erectile dysfunction is the inability to achieve or keep up penile erection in men.

The global drugs for erectile dysfunction market was valued at about $4.28 billion in 2018 and is expected to grow to $5.18 billion at a CAGR of 4.9% through 2022.

The erectile dysfunction drugs market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for erectile dysfunction drugs and is expected to continue to be the largest market during the forecast period.

Drastic increase in the number of chronic diseases drives the erectile dysfunction drugs market. Erectile dysfunction is mainly caused by chronic diseases resulting from sedentary lifestyle such as cardiovascular diseases, diabetes, obesity, and high blood pressure. According to WHO, prevalence of chronic diseases is expected to grow by 57% by the end of year 2020. Prevalence of chronic diseases increases the chances of erectile dysfunction among men, thereby driving the erectile dysfunction drugs market.

Patients suffering from erectile dysfunction do not seek treatment owing to factors such as lack of education, lack of awareness, strong religious beliefs, social taboo, and low socioeconomic status. These factors are responsible for the patients suffering from erectile dysfunction to reject or avoid the treatment. For example, a study conducted by Harlem Hospital in New York City in 2018 among 100 men reveled that more than 86% of the respondents did not have the knowledge that smoking causes erectile dysfunction. These factors restrain the growth of erectile dysfunction drugs market.

New drug delivery techniques such as the use of pellets and creams are being implemented by many companies in the erectile dysfunction drugs market. Pellets and creams will have more efficacy and performance in erectile dysfunction and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of erectile dysfunction drugs market. For example, in 2018, Apricus Biosciences entered into manufacturing cream called vitaros to treat erectile dysfunction.

Medicines are authorized by regulatory bodies based on quality, safety, and efficacy to make sure that medicines are of standard quality and gives positive benefit. Companies are mandated to submit the documentation for the standard quality before applying for the authorization. Safety and efficacy of medicines should be demonstrated by clinical trials for all new medicines by the companies. Competent authorities will assess this data before authorizing the drugs. In Europe, the European Medicines Agency (EMA) assesses the drugs for centrally authorized products.

Major players in the market are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd and Vivus.
Note: Product cover images may vary from those shown
5 of 5
  • Eli Lilly and Co.
  • Pfizer
  • Bayer AG
  • Dong-A Pharmaceutical Co. Ltd
  • Vivus
  • Meda Pharmaceuticals
  • Apricus Biosciences
  • Cristália
  • S.K. Chemicals Co
  • Teva Pharmaceutical Industries Ltd
  • Produtos Quimicos Farmaceuticos Ltd.
  • Johnson & Johnson Services
  • Bonro Medical
  • Post-T-Vac Medical
  • Augusta Medical Systems LLC (Augusta Medical)
  • Zephyr Surgical Implants (ZSI)
  • Premedon
  • Futura Medical
  • Endo International plc
  • Coloplast A/S
  • Boston Scientific Corp
  • Seelos Therapeutics
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll